---
title: "Top 5 港股千億以上公司漲跌幅（2月24日）"
description: "智譜 (02513) 涨 12.14%，成交额 31.6 亿港元，年内累计涨 440.4%。 兆易創新 (03986) 涨 11.91%，成交额 11.4 亿港元，年内累计涨 166.8%。 中國中免 (01880) 跌 10.51%，成交额 8.4 亿港元，年内累计涨 4.2%。 三花智控 (02050) 跌 6.62%，成交额 9.5 亿港元，年内累计跌 6.6%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/276703977.md"
published_at: "2026-02-24T08:30:41.000Z"
---

# Top 5 港股千億以上公司漲跌幅（2月24日）

> 智譜 (02513) 涨 12.14%，成交额 31.6 亿港元，年内累计涨 440.4%。 兆易創新 (03986) 涨 11.91%，成交额 11.4 亿港元，年内累计涨 166.8%。 中國中免 (01880) 跌 10.51%，成交额 8.4 亿港元，年内累计涨 4.2%。 三花智控 (02050) 跌 6.62%，成交额 9.5 亿港元，年内累计跌 6.6%。

恆生指數跌 1.82%，年内累計涨 3.7%；恆生科技指數跌 2.13%，年内累計跌 4.4%。

智譜 (02513) 涨 12.14%，成交额 31.6 亿港元，年内累计涨 440.4%。

兆易創新 (03986) 涨 11.91%，成交额 11.4 亿港元，年内累计涨 166.8%。

中國中免 (01880) 跌 10.51%，成交额 8.4 亿港元，年内累计涨 4.2%。

三花智控 (02050) 跌 6.62%，成交额 9.5 亿港元，年内累计跌 6.6%。

### Related Stocks

- [02513.HK - 智譜](https://longbridge.com/zh-HK/quote/02513.HK.md)
- [03986.HK - 兆易創新](https://longbridge.com/zh-HK/quote/03986.HK.md)
- [02338.HK - 濰柴動力](https://longbridge.com/zh-HK/quote/02338.HK.md)
- [01072.HK - 東方電氣](https://longbridge.com/zh-HK/quote/01072.HK.md)
- [06809.HK - 瀾起科技](https://longbridge.com/zh-HK/quote/06809.HK.md)
- [01880.HK - 中國中免](https://longbridge.com/zh-HK/quote/01880.HK.md)
- [02050.HK - 三花智控](https://longbridge.com/zh-HK/quote/02050.HK.md)
- [01177.HK - 中國生物制藥](https://longbridge.com/zh-HK/quote/01177.HK.md)
- [06181.HK - 老鋪黃金](https://longbridge.com/zh-HK/quote/06181.HK.md)
- [03692.HK - 翰森制藥](https://longbridge.com/zh-HK/quote/03692.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Hansoh Pharmaceutical Says Aumolertinib Mesylate Tablets Approved In EU As Monotherapy | Hansoh Pharmaceutical Group Company Ltd :AUMOLERTINIB MESYLATE TABLETS APPROVED IN EU AS MONOTHERAPY | [Link](https://longbridge.com/zh-HK/news/276401882.md) |
| Hansoh Pharmaceutical Group Company Limited Announces Approval in the European Union as Monotherapy | Hansoh Pharmaceutical Group Company Limited announced that Aumolertinib Mesylate Tablets, known as Ameile in China, rece | [Link](https://longbridge.com/zh-HK/news/276480305.md) |
| Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib | Hansoh Wins EU Approval for Key Lung Cancer Drug Aumolertinib | [Link](https://longbridge.com/zh-HK/news/276393466.md) |
| GigaDevice Fully Exercises Over-Allotment Option After Hong Kong Global Offering | GigaDevice Semiconductor Inc. has fully exercised its over-allotment option in its recent global offering, issuing 4,337 | [Link](https://longbridge.com/zh-HK/news/275225106.md) |
| Is an AI price war about to begin? | The price of AI services is decreasing, with China's Zhipu offering access for about $3 a month, compared to $20 for US  | [Link](https://longbridge.com/zh-HK/news/276415182.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。